CurrentCentenePolicy CP.MP.184

Home ventilators (invasive and noninvasive)

Medical necessity criteria and coverage guidance for noninvasive and invasive home ventilators for non-Medicare health plans affiliated with Centene, including initial and continued use, backup devices, and required documentation.

Policy Summary

PayerCentene

PolicyHome ventilators (invasive and noninvasive)

Policy CodePolicy CP.MP.184

Change TypeRevised, Added, Removed

Effective Date

Next Review Date

Key ActionObtain prior authorization for the initial 3-month period and include diagnosis, baseline measurements (e.g., PaCO2), and justification that RAD/CPAP is inappropriate.

SourceLink

POLICY UPDATE CHANGES

Clarified initial request period is for three months and applied contraindication/usage requirements to each indication; replaced prior BiPAP failure criteria with documentation that member could not be appropriately treated with a RAD and that ventilator will not be used to provide RAD or CPAP therapy.

Added invasive ventilator criteria and HCPCS E0465; combined invasive and noninvasive backup/second ventilator criteria into a single section.

Removed requirements in the obesity hypoventilation syndrome indication for PSG or home test demonstrating <88% O2 saturation.

3 monthsinitial noninvasive ventilator certification period

>=4 hrs/dayminimum average daily device use

E0465, E0466HCPCS codes listed

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Coverage Criteria for Home Ventilators

Initial noninvasive ventilator therapy — restrictive thoracic/neuromuscular disease (first 3 months)

Covered when ALL of the following are met for initial 3-month period:

A1a
- A1a.i: PaCO2 measured while awake (on room air or on prescribed O2) >= 45 mm HgPaCO2 >= 45 mm Hg
- A1a.ii: Sleep oximetry demonstrates O2 saturation < 88% for at least five minutes while breathing prescribed O2SpO2 < 88% >= 5 minutes
- A1a.iii: If neuromuscular disease present: maximal inspiratory pressure <= 60 cm H2O OR forced vital capacity <= 50% predictedMIP <= 60 cm H2O OR FVC <= 50% predicted

A2: Documentation that the member could not be appropriately treated with a respiratory assist device (RAD)

A3: Documentation that the noninvasive ventilator will not be used to provide RAD or CPAP therapy (i.e., will be used to provide average volume assured pressure support)

A4: Chronic obstructive pulmonary disease (COPD) does not contribute significantly to the pulmonary limitation

Initial noninvasive ventilator therapy — severe COPD (first 3 months)

Covered when ALL of the following are met:

B1: Arterial blood gas PaCO2 measured while awake and breathing at baseline on prescribed FiO2 is >= 52 mm HgPaCO2 >= 52 mm Hg

B2: Prior to initiating therapy, apnea and treatment with CPAP has been considered and ruled out unless medical record documents OSA/CSA is not the predominant cause of awake hypercapnia or nocturnal desaturation

Formal testing not required if sleep apnea is not predominant cause

B3: Documentation that the member could not be appropriately treated with a respiratory assist device (RAD)

B4: Documentation that the noninvasive ventilator will not be used to provide RAD or CPAP therapy

Initial noninvasive ventilator therapy — obesity hypoventilation syndrome (OHS) (first 3 months)

Covered when ALL of the following are met:

C1: Body mass index (BMI) >= 30BMI >= 30

C2: An initial arterial blood gas PaCO2 measured while awake and breathing at baseline has been obtained

C3: Sleep-disordered hypoventilation has been documented by polysomnography and other conditions are not the primary cause of hypoventilation

Policy removed prior requirement for PSG/home test demonstrating <88% O2 saturation in a revision

C4: Documentation that the member could not be appropriately treated with a respiratory assist device (RAD)

Continued noninvasive ventilator use (after initial 3-month certification)

Covered when ALL of the following are met:

II.A: Device is used for at least an average of four hours per 24-hour period>= 4 hours/day average

II.B.1: Ongoing benefits from use of the device are documented

II.B.2: Documentation that the noninvasive home ventilator is not being used to provide RAD or CPAP therapy

Invasive ventilator therapy (initial and ongoing)

Initial and ongoing use of an invasive ventilator is medically necessary for long-term/chronic conditions when ALL of the following apply:

IV.1: Long-term/chronic condition or disease affecting ability to maintain adequate respiratory status (examples: neuromuscular disease, thoracic restrictive disease, or chronic respiratory failure following COPD)

Invasive ventilation indicated when noninvasive ventilation is contraindicated or insufficient

Second or backup ventilator

A second or backup ventilator is considered medically necessary when ANY of the following apply:

V.A: A second ventilator is required to serve a different purpose from the first ventilator (e.g., two different types needed to meet medical needs)

V.B: Member is confined to a wheelchair and requires a wheelchair-mounted ventilator during the day and another ventilator for use while in bed

Failure to have both may lead to medical complications

V.C: Residence in remote areas with poor emergency access

Use of a noninvasive home ventilator to provide a respiratory assist device (RAD) or CPAP therapy is excluded when the device is intended to provide ventilator-level support rather than RAD/CPAP. Documentation must clearly demonstrate that the ventilator is being used for ventilatory support (for example, average volume assured pressure support) and will not be used to deliver RAD or CPAP therapy.

Prior policy language that required demonstration of BiPAP failure has been removed. Instead, requests must include explicit documentation that the member could not be appropriately treated with a RAD and that the noninvasive ventilator will not be used to provide RAD or CPAP therapy. This documentation is required at initial authorization and for ongoing coverage to distinguish true ventilator-level support from RAD/CPAP use.

Coding and Authorization Details

Covered HCPCS Codes for home ventilatorsHCPCSCovered

E0465	Home ventilator, any type, used with invasive interface, (e.g,, tracheostomy tube).
E0466	Home ventilator, any type, used with noninvasive interface, (e.g,, mask, chest shell).

Initial prior authorization duration

Initial authorization period3 months (initial prior authorization required for the first three months of noninvasive ventilator use)

Applies toInitial requests for noninvasive home ventilator use (restrictive thoracic, neuromuscular disease, severe COPD, OHS)

Required inclusion with requestDiagnosis, baseline measurements (e.g., PaCO2), and justification that RAD/CPAP is inappropriate

Minimum average daily use for continued coverage

Minimum average daily useAt least 4 hours per 24-hour period (average)

PurposeDemonstrates ongoing therapeutic benefit for continued coverage after initial 3‑month certification

Provider Actions and Documentation Requirements

Prior Authorization

Prior authorization — initial 3‑month period

Initial prior authorization is required for the first three months of noninvasive home ventilator use. The request must include the diagnosis, baseline measurements (for example PaCO2), and justification that a respiratory assist device (RAD) or CPAP is inappropriate and that the ventilator will not be used to provide RAD/CPAP therapy.

Covered HCPCS codes: E0465, E0466

Step Therapy

Consider CPAP/RAD first — rule out or document inability to use RAD/CPAP

Before initiating ventilator therapy for certain indications (e.g., severe COPD), CPAP and use of a respiratory assist device (RAD) must be considered and ruled out; formal sleep testing is not required if the record documents that obstructive or central sleep apnea is not the predominant cause of awake hypercapnia or nocturnal desaturation.

Documentation must show RAD/CPAP was considered and ruled out or that sleep apnea is not the predominant cause of hypercapnia/nocturnal desaturation.

Key Definitions

Noninvasive ventilation (NIV) — definition and examples

DefinitionAdministration of positive pressure to the lungs using noninvasive interfaces (examples: nasal masks, orofacial masks, full‑face masks, mouthpieces, nasal pillows, helmets)

Primary purposeSupport ventilation without an invasive airway for acute or chronic respiratory failure

Common modes/interfacesBi‑level positive airway pressure (BiPAP), pressure support, volume ventilation delivered via mask or similar interface

Invasive ventilation — definition and examples

DefinitionAdministration of positive pressure to the lungs through an invasive interface (examples: tracheostomy tube, endotracheal tube)

IndicationsUsed when patients cannot maintain adequate ventilation spontaneously or require airway protection (e.g., decreased consciousness, aspiration risk)

Background

Respiratory failure is the inability to maintain adequate oxygenation or to eliminate carbon dioxide and may be acute or chronic. Noninvasive ventilation (NIV) delivers positive pressure through masks or other noninvasive interfaces to support ventilation without an invasive airway. NIV can reduce symptoms, improve quality of life, decrease readmissions, and in selected patients provide mortality benefit. In contrast, invasive ventilation uses an artificial airway (for example, a tracheostomy) when patients cannot maintain ventilation spontaneously or require airway protection.